(AXP) American Express - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0258161092
Stock: Cards, Payments, Loans, Merchant Services, Network
Total Rating 34
Risk 37
Buy Signal 0.40
| Risk 5d forecast | |
|---|---|
| Volatility | 40.1% |
| Relative Tail Risk | -4.69% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.45 |
| Alpha | -4.63 |
| Character TTM | |
|---|---|
| Beta | 1.211 |
| Beta Downside | 1.312 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.76% |
| CAGR/Max DD | 0.90 |
EPS (Earnings per Share)
Revenue
Description: AXP American Express February 25, 2026
American Express (AXP) operates an integrated payments platform across four segments-U.S. Consumer Services, Commercial Services, International Card Services, and Global Merchant & Network Services-serving individuals, small-business owners, midsize firms, and large corporations through cards, financing, merchant processing, and a suite of travel, dining, and expense-management solutions.
In FY 2023 the company generated $58 billion in revenue, up 5% year-over-year, with net income of $7.5 billion and diluted EPS of $5.75. Card volume rose 8% YoY to $1.3 trillion, driven by a resurgence in travel and dining spend, while net interest income climbed 12% as higher interest rates lifted credit-card yields. The consumer-finance sector remains sensitive to discretionary spending trends and the competitive pressure from fintech players expanding digital-only card offerings.
For a deeper dive into AXP’s valuation metrics and scenario analysis, you might explore ValueRay’s research tools.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 10.83b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.86 > 1.0 |
| NWC/Revenue: -152.0% < 20% (prev -155.4%; Δ 3.41% < -1%) |
| CFO/TA 0.06 > 3% & CFO 18.43b > Net Income 10.83b |
| Net Debt (10.05b) to EBITDA (15.11b): 0.67 < 3 |
| Current Ratio: 0.28 > 1.5 & < 3 |
| Outstanding Shares: last quarter (688.0m) vs 12m ago -2.27% < -2% |
| Gross Margin: 83.23% > 18% (prev 0.82%; Δ 8242 % > 0.5%) |
| Asset Turnover: 28.16% > 50% (prev 27.33%; Δ 0.82% > 0%) |
| Interest Coverage Ratio: 1.30 > 6 (EBITDA TTM 15.11b / Interest Expense TTM 8.23b) |
Altman Z'' -2.06
| A: -0.41 (Total Current Assets 48.53b - Total Current Liabilities 170.81b) / Total Assets 300.05b |
| B: 0.08 (Retained Earnings 25.49b / Total Assets 300.05b) |
| C: 0.04 (EBIT TTM 10.71b / Avg Total Assets 285.76b) |
| D: 0.08 (Book Value of Equity 22.35b / Total Liabilities 266.58b) |
| Altman-Z'' Score: -2.06 = D |
Beneish M -1.17
| DSRI: 3.23 (Receivables 207.77b/59.24b, Revenue 80.46b/74.20b) |
| GMI: 0.98 (GM 83.23% / 81.89%) |
| AQI: 0.99 (AQ_t 0.81 / AQ_t-1 0.82) |
| SGI: 1.08 (Revenue 80.46b / 74.20b) |
| TATA: -0.03 (NI 10.83b - CFO 18.43b) / TA 300.05b) |
| Beneish M-Score: -1.17 (Cap -4..+1) = D |
What is the price of AXP shares?
As of February 27, 2026, the stock is trading at USD 335.32 with a total of 3,214,921 shares traded.
Over the past week, the price has changed by -2.14%, over one month by -7.69%, over three months by -7.67% and over the past year by +14.45%.
Over the past week, the price has changed by -2.14%, over one month by -7.69%, over three months by -7.67% and over the past year by +14.45%.
Is AXP a buy, sell or hold?
American Express has received a consensus analysts rating of 3.53.
Therefor, it is recommend to hold AXP.
- StrongBuy: 7
- Buy: 4
- Hold: 18
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the AXP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 379.4 | 13.1% |
| Analysts Target Price | 379.4 | 13.1% |
AXP Fundamental Data Overview February 21, 2026
P/E Trailing = 22.5279
P/E Forward = 18.8324
P/S = 3.5243
P/B = 7.0284
P/EG = 1.9199
Revenue TTM = 80.46b USD
EBIT TTM = 10.71b USD
EBITDA TTM = 15.11b USD
Long Term Debt = 56.39b USD (from longTermDebt, last quarter)
Short Term Debt = 1.37b USD (from shortTermDebt, last quarter)
Debt = 57.76b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.05b USD (from netDebt column, last quarter)
Enterprise Value = 250.30b USD (236.04b + Debt 57.76b - CCE 43.49b)
Interest Coverage Ratio = 1.30 (Ebit TTM 10.71b / Interest Expense TTM 8.23b)
EV/FCF = 15.64x (Enterprise Value 250.30b / FCF TTM 16.00b)
FCF Yield = 6.39% (FCF TTM 16.00b / Enterprise Value 250.30b)
FCF Margin = 19.89% (FCF TTM 16.00b / Revenue TTM 80.46b)
Net Margin = 13.46% (Net Income TTM 10.83b / Revenue TTM 80.46b)
Gross Margin = 83.23% ((Revenue TTM 80.46b - Cost of Revenue TTM 13.49b) / Revenue TTM)
Gross Margin QoQ = 83.49% (prev 83.37%)
Tobins Q-Ratio = 0.83 (Enterprise Value 250.30b / Total Assets 300.05b)
Interest Expense / Debt = 3.57% (Interest Expense 2.06b / Debt 57.76b)
Taxrate = 20.32% (628.0m / 3.09b)
NOPAT = 8.53b (EBIT 10.71b * (1 - 20.32%))
Current Ratio = 0.28 (Total Current Assets 48.53b / Total Current Liabilities 170.81b)
Debt / Equity = 1.73 (Debt 57.76b / totalStockholderEquity, last quarter 33.47b)
Debt / EBITDA = 0.67 (Net Debt 10.05b / EBITDA 15.11b)
Debt / FCF = 0.63 (Net Debt 10.05b / FCF TTM 16.00b)
Total Stockholder Equity = 32.35b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.79% (Net Income 10.83b / Total Assets 300.05b)
RoE = 33.49% (Net Income TTM 10.83b / Total Stockholder Equity 32.35b)
RoCE = 12.06% (EBIT 10.71b / Capital Employed (Equity 32.35b + L.T.Debt 56.39b))
RoIC = 9.51% (NOPAT 8.53b / Invested Capital 89.72b)
WACC = 8.90% (E(236.04b)/V(293.79b) * Re(10.38%) + D(57.76b)/V(293.79b) * Rd(3.57%) * (1-Tc(0.20)))
Discount Rate = 10.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.65%
[DCF] Terminal Value 74.86% ; FCFF base≈14.46b ; Y1≈14.45b ; Y5≈15.27b
[DCF] Fair Price = 318.2 (EV 228.53b - Net Debt 10.05b = Equity 218.48b / Shares 686.6m; r=8.90% [WACC]; 5y FCF grow -0.66% → 2.90% )
EPS Correlation: 78.39 | EPS CAGR: 7.09% | SUE: -0.07 | # QB: 0
Revenue Correlation: 95.48 | Revenue CAGR: 16.85% | SUE: 2.28 | # QB: 1
EPS next Quarter (2026-03-31): EPS=3.99 | Chg7d=-0.002 | Chg30d=+0.004 | Revisions Net=-5 | Analysts=22
EPS current Year (2026-12-31): EPS=17.55 | Chg7d=-0.005 | Chg30d=+0.161 | Revisions Net=+11 | Growth EPS=+14.1% | Growth Revenue=+9.0%
EPS next Year (2027-12-31): EPS=20.10 | Chg7d=+0.028 | Chg30d=+0.149 | Revisions Net=+6 | Growth EPS=+14.5% | Growth Revenue=+9.2%
[Analyst] Revisions Ratio: -0.33 (5 Up / 10 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.9% (Discount Rate 10.4% - Earnings Yield 4.4%)
[Growth] Growth Spread = +3.6% (Analyst 9.6% - Implied 5.9%)
P/E Forward = 18.8324
P/S = 3.5243
P/B = 7.0284
P/EG = 1.9199
Revenue TTM = 80.46b USD
EBIT TTM = 10.71b USD
EBITDA TTM = 15.11b USD
Long Term Debt = 56.39b USD (from longTermDebt, last quarter)
Short Term Debt = 1.37b USD (from shortTermDebt, last quarter)
Debt = 57.76b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.05b USD (from netDebt column, last quarter)
Enterprise Value = 250.30b USD (236.04b + Debt 57.76b - CCE 43.49b)
Interest Coverage Ratio = 1.30 (Ebit TTM 10.71b / Interest Expense TTM 8.23b)
EV/FCF = 15.64x (Enterprise Value 250.30b / FCF TTM 16.00b)
FCF Yield = 6.39% (FCF TTM 16.00b / Enterprise Value 250.30b)
FCF Margin = 19.89% (FCF TTM 16.00b / Revenue TTM 80.46b)
Net Margin = 13.46% (Net Income TTM 10.83b / Revenue TTM 80.46b)
Gross Margin = 83.23% ((Revenue TTM 80.46b - Cost of Revenue TTM 13.49b) / Revenue TTM)
Gross Margin QoQ = 83.49% (prev 83.37%)
Tobins Q-Ratio = 0.83 (Enterprise Value 250.30b / Total Assets 300.05b)
Interest Expense / Debt = 3.57% (Interest Expense 2.06b / Debt 57.76b)
Taxrate = 20.32% (628.0m / 3.09b)
NOPAT = 8.53b (EBIT 10.71b * (1 - 20.32%))
Current Ratio = 0.28 (Total Current Assets 48.53b / Total Current Liabilities 170.81b)
Debt / Equity = 1.73 (Debt 57.76b / totalStockholderEquity, last quarter 33.47b)
Debt / EBITDA = 0.67 (Net Debt 10.05b / EBITDA 15.11b)
Debt / FCF = 0.63 (Net Debt 10.05b / FCF TTM 16.00b)
Total Stockholder Equity = 32.35b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.79% (Net Income 10.83b / Total Assets 300.05b)
RoE = 33.49% (Net Income TTM 10.83b / Total Stockholder Equity 32.35b)
RoCE = 12.06% (EBIT 10.71b / Capital Employed (Equity 32.35b + L.T.Debt 56.39b))
RoIC = 9.51% (NOPAT 8.53b / Invested Capital 89.72b)
WACC = 8.90% (E(236.04b)/V(293.79b) * Re(10.38%) + D(57.76b)/V(293.79b) * Rd(3.57%) * (1-Tc(0.20)))
Discount Rate = 10.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.65%
[DCF] Terminal Value 74.86% ; FCFF base≈14.46b ; Y1≈14.45b ; Y5≈15.27b
[DCF] Fair Price = 318.2 (EV 228.53b - Net Debt 10.05b = Equity 218.48b / Shares 686.6m; r=8.90% [WACC]; 5y FCF grow -0.66% → 2.90% )
EPS Correlation: 78.39 | EPS CAGR: 7.09% | SUE: -0.07 | # QB: 0
Revenue Correlation: 95.48 | Revenue CAGR: 16.85% | SUE: 2.28 | # QB: 1
EPS next Quarter (2026-03-31): EPS=3.99 | Chg7d=-0.002 | Chg30d=+0.004 | Revisions Net=-5 | Analysts=22
EPS current Year (2026-12-31): EPS=17.55 | Chg7d=-0.005 | Chg30d=+0.161 | Revisions Net=+11 | Growth EPS=+14.1% | Growth Revenue=+9.0%
EPS next Year (2027-12-31): EPS=20.10 | Chg7d=+0.028 | Chg30d=+0.149 | Revisions Net=+6 | Growth EPS=+14.5% | Growth Revenue=+9.2%
[Analyst] Revisions Ratio: -0.33 (5 Up / 10 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.9% (Discount Rate 10.4% - Earnings Yield 4.4%)
[Growth] Growth Spread = +3.6% (Analyst 9.6% - Implied 5.9%)